OrbusNeich Honored with the “Outstanding Caring Award” and “The Most Devoted Award” at Industry Cares 2026

(Hong Kong, October 13, 2026) – OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a multinational medical device company specializing in interventional solutions for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures,

has received the “Outstanding Caring Award” and “The Most Devoted Award” in the Startup and SME Category of the Industry Cares Recognition Scheme 2026, organized by the Federation of Hong Kong Industries (FHKI). The awards recognize OrbusNeich’s sustained commitment to corporate social responsibility (CSR) through strategic community investment, active employee engagement, and cross-sector collaboration, creating meaningful and lasting social impact in Hong Kong.

OrbusNeich has long pursued a “grow-with-the-community” approach, aligning corporate resources, professional expertise, and employee participation with societal needs. Over the past year, the Group partnered with non-profit organizations, schools, charitable foundations, and professional bodies to deliver community initiatives across health, education, inclusion, and youth development, continuing to create shared value for society.

Key initiatives include the Go! Grow! Glow! Secondary School Transition Program, which supports students from grassroots families in the North District and their parents through mock interviews, school transition workshops, parent–child activities, and parenting seminars to build confidence, adaptability, and family communication; and the Independent Living and Career Exploration Partnership Program, which assists adults with intellectual disabilities in residential care homes and local secondary school students through independent shopping experiences, career exploration days, Human Library activities, and career discovery programs to develop independent living skills and expand education and career pathways. Through these programs, OrbusNeich’s management and employees serve as volunteers, mentors, and speakers, sharing professional expertise and personal experience with the community.

The Group continues to advance its Hong Kong Community Wellbeing Program, supporting World Heart Day, cardiovascular health education, scholarships, youth development initiatives, and charitable projects that raise public health awareness and assist underprivileged groups. Leveraging its expertise in cardiovascular care, the program also supports professional training and knowledge-sharing platforms that empower healthcare professionals, advance medical innovation, and improve patient outcomes.

Looking ahead, OrbusNeich will build on its strengths in medical expertise, collaborative partnerships, and employee engagement to further deepen its CSR efforts. The Group remains committed to launching more initiatives that promote health, inclusion, and youth development—creating greater shared value for the Hong Kong community and contributing to the city’s sustainable development and social cohesion.

The Industry Cares Recognition Scheme 2026 award presentation ceremony was held on October 8, with Ms. Maggie Lau, Corporate Communications Manager (left), accepting the award on behalf of OrbusNeich.

－ End －

About OrbusNeich Medical Group Holdings Limited
OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 25 years of product development expertise, our Group has developed world-leading proprietary technologies.

For more information, please visit the Group’s official website: https://orbusneich.com/.